{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:16:11Z","timestamp":1761488171146,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.annfar.2008.10.020","type":"journal-article","created":{"date-parts":[[2008,12,24]],"date-time":"2008-12-24T08:42:43Z","timestamp":1230108163000},"page":"91-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Choc toxique staphylococcique dans un contexte menstruel de port de tampons vaginaux d\u2019\u00e9volution favorable apr\u00e8s optimisation h\u00e9modynamique pr\u00e9coce et administration de prot\u00e9ine\u00a0C activ\u00e9e"],"prefix":"10.1016","volume":"28","author":[{"given":"E.","family":"Ellies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Vall\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bauriaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Fourcade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Genestal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annfar.2008.10.020_bib1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0750-7658(02)00621-4","article-title":"\u00c9pid\u00e9miologie des infections tox\u00e9miques \u00e0 Staphylocoque dor\u00e9","volume":"21","author":"Jarraud","year":"2002","journal-title":"Ann Fr Anesth Reanim"},{"issue":"Suppl. 2","key":"10.1016\/j.annfar.2008.10.020_bib2","first-page":"S25","article-title":"Recognition and management of Staphylococcus aureus toxin-mediated disease","volume":"35","author":"Murray","year":"2005","journal-title":"Intern Med J"},{"key":"10.1016\/j.annfar.2008.10.020_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/CMR.13.1.16","article-title":"Exotoxins of Staphylococcus aureus","volume":"13","author":"Dinges","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.annfar.2008.10.020_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jmr.612","article-title":"Therapeutic approaches to superantigens-based diseases: a review","volume":"16","author":"Hong-Geller","year":"2003","journal-title":"J Mol Recognit"},{"key":"10.1016\/j.annfar.2008.10.020_bib5","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/01.CCM.0000117317.18092.E4","article-title":"Surviving sepsis campaign guidelines for management of severe sepsis and septic shock","volume":"32","author":"Dellinger","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.annfar.2008.10.020_bib6","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy in the treatment of severe sepsis and septic shock","volume":"345","author":"Rivers","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2008.10.020_bib7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.annfar.2005.10.005","article-title":"Sepsis s\u00e9v\u00e8re\u00a0: le contr\u00f4le glyc\u00e9mique","volume":"25","author":"Orban","year":"2006","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.annfar.2008.10.020_bib8","series-title":"Congr\u00e8s national d\u2019anesth\u00e9sie et de r\u00e9animation. Conf\u00e9rences d\u2019actualisation","first-page":"285","article-title":"Immunit\u00e9 et polymorphismes g\u00e9n\u00e9tiques","author":"Mira","year":"2004"},{"key":"10.1016\/j.annfar.2008.10.020_bib9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein\u00a0C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl J Med"},{"issue":"Suppl. 5","key":"10.1016\/j.annfar.2008.10.020_bib10","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/cc6158","article-title":"Practical aspectsof treatment with drotrecogin alpha (activated)","volume":"11","author":"Camporota","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.annfar.2008.10.020_bib11","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2165\/00002018-200730110-00002","article-title":"Benefit-risk assessment of drotrecogin alpha (activated) in the treatment of sepsis","volume":"30","author":"De Backer","year":"2007","journal-title":"Drug Saf"},{"key":"10.1016\/j.annfar.2008.10.020_bib12","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1517\/14712598.7.11.1763","article-title":"Drotrecogin alpha (activated): the treatment for severe sepsis?","volume":"7","author":"Vincent","year":"2007","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.annfar.2008.10.020_bib13","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1128\/JCM.43.9.4628-4634.2005","article-title":"Prevalence of toxic shock syndrome toxin-1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women","volume":"43","author":"Parsonnet","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.annfar.2008.10.020_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/01.CCM.0000150025.79100.7D","article-title":"Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor and interleukin-1-related gene polymorphisms","volume":"33","author":"Watanabe","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.annfar.2008.10.020_bib15","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1097\/01.CCM.0000220498.48773.3C","article-title":"Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis","volume":"34","author":"De Backer","year":"2006","journal-title":"Crit Care Med"},{"issue":"Suppl. 5","key":"10.1016\/j.annfar.2008.10.020_bib16","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/cc6154","article-title":"Recombinant human activated protein C: current insights into its of action","volume":"11","author":"Levi","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.annfar.2008.10.020_bib17","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.1097\/01.CCM.0000126363.46191.DC","article-title":"Importance of hemostatic gene polymorphisms for susceptibility to and outcome of severe sepsis","volume":"32","author":"Texereau","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.annfar.2008.10.020_bib18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1164-6756(01)00124-4","article-title":"Traitement des infections \u00e0 Staphylocoques r\u00e9sistants \u00e0 la m\u00e9ticilline\u00a0: optimisation des traitements disponibles ou utilisation de nouvelles mol\u00e9cules","volume":"10","author":"Gibert","year":"2001","journal-title":"R\u00e9animation"},{"key":"10.1016\/j.annfar.2008.10.020_bib19","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0750-7658(02)00626-3","article-title":"Association d\u2019antibiotiques dans les infections \u00e0 Staphylocoque dor\u00e9\u00a0: les arguments pour","volume":"21","author":"Potel","year":"2002","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.annfar.2008.10.020_bib20","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0750-7658(02)00624-X","article-title":"Principes th\u00e9rapeutiques des infections \u00e0 Staphylocoques. Place et limites des mol\u00e9cules classiques","volume":"21","author":"Doment","year":"2002","journal-title":"Ann Fr Anesth Reanim"}],"container-title":["Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075076580800590X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075076580800590X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:09:28Z","timestamp":1760090968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075076580800590X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S075076580800590X"],"URL":"https:\/\/doi.org\/10.1016\/j.annfar.2008.10.020","relation":{},"ISSN":["0750-7658"],"issn-type":[{"type":"print","value":"0750-7658"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Choc toxique staphylococcique dans un contexte menstruel de port de tampons vaginaux d\u2019\u00e9volution favorable apr\u00e8s optimisation h\u00e9modynamique pr\u00e9coce et administration de prot\u00e9ine\u00a0C activ\u00e9e","name":"articletitle","label":"Article Title"},{"value":"Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annfar.2008.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}